Open Access Policy

Advancing Stem Cell Research through Open Access

The Journal of Stem Cell Therapy and Transplantation (JSCTT) is committed to disseminating high-quality research in regenerative medicine, stem cell biology, and transplantation sciences. By following an open-access publishing model, we ensure that groundbreaking research is accessible to scientists, clinicians, and the wider medical community without restrictions.

All published articles in JSCTT are freely available, supporting the rapid exchange of knowledge and fostering innovation in stem cell therapies and transplantation science.

Unrestricted Access to Life-Saving Research

By adopting open-access principles, JSCTT ensures:

  • Global accessibility to the latest advances in stem cell therapy and transplantation.
  • Enhanced collaboration among researchers, medical professionals, and biotech industries.
  • Faster implementation of new treatments and regenerative medicine approaches.

This model accelerates the translation of stem cell research into clinical applications, improving patient care and medical outcomes worldwide.

Copyright and Licensing

All articles published in JSCTT are licensed under the Creative Commons Attribution License (CC BY 4.0). This allows researchers and institutions to share, adapt, and build upon published work, provided proper credit is given to the original authors.

This licensing model ensures that vital scientific discoveries in stem cell research remain open and reusable, driving further advancements in regenerative medicine.

Article Processing Charges (APCs)

To sustain our open-access model, JSCTT applies a reasonable Article Processing Charge (APC). This fee covers:

  • High-quality peer review and editorial management.
  • Professional formatting, DOI registration, and digital archiving.
  • Wide dissemination across global research networks.

Fee waivers and financial support options are available for researchers from low-income countries to encourage diversity in scientific publishing.

Ensuring Long-Term Preservation of Research

To guarantee the long-term accessibility of published articles, JSCTT collaborates with leading digital archiving services, including:

  • Portico – A secure digital preservation archive.
  • LOCKSS – Decentralized archiving for long-term research availability.
  • CrossRef – DOI integration for citation tracking.

These preservation initiatives ensure that stem cell research remains accessible for future generations of scientists and clinicians.

Commitment to Open Science

As part of the global open-science movement, JSCTT actively promotes:

  • Open Data: Authors are encouraged to share research datasets to enhance transparency.
  • Preprint Archives: Early research dissemination to accelerate scientific discovery.
  • Transparent Peer Review: A rigorous and open evaluation process.

These initiatives support ethical research practices and contribute to breakthroughs in stem cell therapy and transplantation.

Benefits of Publishing Open Access

Authors publishing in JSCTT benefit from:

  • Global Readership: Research is accessible to scientists, clinicians, and biotech industries worldwide.
  • Higher Citations: Open-access articles receive greater visibility and impact.
  • Faster Research Translation: Findings are quickly applied in clinical and experimental settings.
  • Unrestricted Use: Research can be freely shared and adapted with appropriate credit.

By removing access barriers, we empower scientists and healthcare professionals to advance regenerative medicine and life-saving therapies.

Join the Open-Access Movement

JSCTT invites stem cell researchers, transplant specialists, and medical professionals to contribute to open-access publishing and drive innovation in regenerative medicine.

For more details on manuscript submission and our open-access policies, visit our journal website or contact our editorial office at [email protected].